Dark

Check out our Level2View

SSKN
STRATA SKIN SCIENCES INC
stock OTC

EOD

Jun 25, 2026

0.1310USD+8.264%(+0.0100)324

Pre-market

0.00USD-100.000%(-0.12)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 19, 2022

07:40AM EST The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data Benzinga

Jan 18, 2022

04:06PM EST STRATA Skin Sciences Expands Into Israel With Leading Medical Device Distributor Benzinga

04:05PM EST STRATA Skin Sciences Expands into Israel with Leading Medical GlobeNewswire Inc

Jan 11, 2022

08:36AM EST The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In Benzinga

06:43AM EST STRATA Skin Sciences Acquires Theravant's Acne Treatment Device, Expects Upside Q4 Sales Benzinga

Jan 10, 2022

04:11PM EST STRATA Skin Sciences Sees Q4 Sales $8.8M-$9.2M Vs. $8.19M Est., FY21 Sales $29.7M-$30.1M Vs. $29.11M Est. Benzinga

04:10PM EST STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today reported preliminary, unaudited fourth quarter 2021 financial results. GlobeNewswire Inc

04:02PM EST STRATA Skin Sciences Announces Acquisition Of Acne Treatment Device Assets From Theravant Corporation For ~$1M Upfront Payment And Milestone-Based Payments Benzinga

04:01PM EST STRATA Skin Sciences Announces Acquisition of Acne Treatment GlobeNewswire Inc

Dec 27, 2021

04:01PM EST STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that members of Management will participate in the upcoming H.C. Wainwright Bioconnect Virtual Conference. GlobeNewswire Inc

Dec 9, 2021

04:01PM EST STRATA Skin Sciences Announces Board of Directors Transition GlobeNewswire Inc

Nov 10, 2021

04:04PM EST Strata Skin Sciences Q3 EPS $(0.02) Beats $(0.05) Estimate, Sales $7.70M Beat $7.53M Estimate Benzinga

04:01PM EST STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended September 30, 2021. GlobeNewswire Inc

04:09AM EST Earnings Scheduled For November 10, 2021 Benzinga

Oct 27, 2021

04:05PM EDT STRATA Skin Sciences to Report Third Quarter 2021 Financial GlobeNewswire Inc

Oct 12, 2021

05:00PM EDT Strata Skin Sciences Amends Shelf Offering Filed August 13 To Disclosed Size Of Mixed Shelf Offering Of Up To $25M Benzinga

Oct 6, 2021

08:35AM EDT PDS Biotechnology Names Matthew Hill As CFO Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Oct 4, 2021

04:06PM EDT STRATA Skin Names Christopher Lesovitz CFO Benzinga

04:05PM EDT STRATA Skin Sciences Announces CFO Transition GlobeNewswire Inc

12:05PM EDT Looking Into Strata Skin Sciences's Return On Capital Employed Benzinga

Sep 29, 2021

08:00AM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that the Company has been invited to present at the Fall Harvest Best Ideas from the Buy-Side conference. CEO, Robert J. Moccia will present at the conference. GlobeNewswire Inc

Sep 2, 2021

04:05PM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in two upcoming investor conferences. GlobeNewswire Inc

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

05:52AM EDT The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.37 A.M. EDT). RTTNews

05:16AM EDT Ra Medical To Focus On Peripheral Artery Disease With Pharos Dermatology Divestiture Benzinga

Aug 16, 2021

04:06PM EDT STRATA Skin Sciences Announces Acquisition of the U.S. Dermatology Business of Ra Medical Systems For $3.7M Upfront Benzinga

04:05PM EDT Strata Skin Sciences Q2 EPS $(0.03) Beats $(0.04) Estimate, Sales $7.40M Beat $6.57M Estimate Benzinga

04:03PM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended June 30, 2021. GlobeNewswire Inc

04:01PM EDT -- Positions STRATA as the predominant provider of excimer laser treatments to address the $6 billion U.S. market for the treatment of chronic skin diseases -- Delivers added long-term recurring revenue growth potential and prospective customer base -- Increases competitive positioning with more than 400 U.S. dermatology practices GlobeNewswire Inc

04:04AM EDT Earnings Scheduled For August 16, 2021 Benzinga

Aug 15, 2021

12:16PM EDT The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

11:06AM EDT The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

Aug 2, 2021

04:01PM EDT STRATA Skin Sciences to Report Second Quarter 2021 Financial GlobeNewswire Inc

08:00AM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (STRATA or the Company), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of Brent Cowgill as Vice President of Marketing. GlobeNewswire Inc

May 18, 2021

08:00AM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming Oppenheimer MedTech, Tools & Diagnostics Summit. GlobeNewswire Inc

May 12, 2021

04:15PM EDT Strata Skin Sciences Q1 EPS $(0.07) Misses $(0.04) Estimate, Sales $5.80M Miss $5.99M Estimate Benzinga

04:01PM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended March 31, 2021. GlobeNewswire Inc

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

04:22AM EDT Earnings Scheduled For May 12, 2021 Benzinga

Apr 28, 2021

08:00AM EDT STRATA Skin Sciences to Report First Quarter 2021 Financial GlobeNewswire Inc

Apr 12, 2021

04:05PM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of William D. Humphries to its Board of Directors. GlobeNewswire Inc

Mar 24, 2021

05:04PM EDT Recap: Strata Skin Sciences Q4 Earnings Benzinga

04:01PM EDT Strata Skin Sciences Q4 EPS $(0.01) Beats $(0.03) Estimate, Sales $6.70M Beat $6.69M Estimate Benzinga

04:00PM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (STRATA or the Company), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter and full year ended December 31, 2020. GlobeNewswire Inc

08:59AM EDT The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping Benzinga

04:29AM EDT Earnings Scheduled For March 24, 2021 Benzinga

Mar 18, 2021

08:16AM EDT The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq Benzinga

Mar 16, 2021

08:00AM EDT STRATA Skin Sciences, Inc. (STRATA) (NASDAQ: SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will participate in the upcoming Lytham Partners Spring 2021 Investor Conference. GlobeNewswire Inc

Mar 15, 2021

08:04AM EDT STRATA Skin Sciences Announces Independent Study Published in the Journal of The European Academy of Dermatology and Venereology Benzinga

08:00AM EDT Vitiligo Repigmentation Achieved in Five Treatments with XTRAC Excimer Laser GlobeNewswire Inc

Mar 10, 2021

08:00AM EST STRATA Skin Sciences to Report Fourth Quarter and Full Year 2020 GlobeNewswire Inc

Mar 9, 2021

09:17AM EST STRATA Skin Sciences Announces Expanded Distribution Agreement In China With Wuhan Miracle Laser Systems; Says Deal Provides Recurring Revenues For Both Companies Benzinga

08:00AM EST STRATA Skin Sciences Announces Expanded Distribution Agreement in GlobeNewswire Inc

Mar 1, 2021

05:35PM EST STRATA Skin Sciences, Inc. Announces Inducement Grants Under GlobeNewswire Inc

07:16AM EST STRATA Skin Sciences Names Robert Moccia President And CEO And A Member Of Board RTTNews

07:09AM EST STRATA Skin Sciences Announces Robert (Bob) Moccia Has Been Appointed President & CEO Benzinga

07:00AM EST STRATA Skin Sciences Announces CEO Transition GlobeNewswire Inc

Jan 12, 2021

08:13AM EST STRATA Skin Sciences Says As Of Dec. 31, 2020 Co Had Cash, Cash Equivalents $18M Vs $15.6M YoY Benzinga

08:11AM EST STRATA Skin Sciences Sees Q4 2020 Revs $6.6M-$6.8M Vs $6.05M-$8.08M Est. Benzinga

08:05AM EST Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 millionPreliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 millionWorldwide installed base increased by 23 placements in the fourth quarter GlobeNewswire Inc

08:00AM EST STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the introduction of a new business, branded Home by XTRAC. GlobeNewswire Inc

Jan 6, 2021

11:15AM EST STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (STRATA or the Company), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming H.C. Wainwright BioConnect Virtual Conference. GlobeNewswire Inc

Dec 28, 2020

08:00AM EST STRATA Skin Sciences, Inc. Announces Successful Renewal of Note GlobeNewswire Inc

Nov 10, 2020

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

08:31AM EST Strata Skin Sciences: Q3 Earnings Insights Benzinga

08:02AM EST Strata Skin Sciences Q3 EPS $(0.04), Inline, Sales $5.60M Beat $4.90M Estimate Benzinga

08:00AM EST STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (STRATA), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended September 30, 2020. GlobeNewswire Inc

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Nov 5, 2020

08:00AM EST STRATA Skin Sciences to Present at Three Upcoming Investor Conferences GlobeNewswire Inc

Nov 3, 2020

08:00AM EST STRATA Skin Sciences to Report Third Quarter 2020 Financial GlobeNewswire Inc

06:12AM EST HC Wainwright & Co. Upgrades Strata Skin Sciences to Buy, Announces $3 Price Target Benzinga

Nov 2, 2020

08:38AM EST Strata Skin Sciences Highlights Publication Of Study Titled 'Therapies for Psoriasis: Clinical and Economic Comparisons'; Says Its XTRAC Technology Was 'found to deliver the fastest results with the fewest adverse events at the most economical cost' Benzinga

08:30AM EST Delivers fastest results with fewest adverse eventscompared to topical, traditional UV, biologic and systemic therapiesProviding a better solution for Integrated Health Systems and Capitation healthcare managing the patients and reducing costs for chronic skin diseaseUp to 97% savings over Biologic drugs GlobeNewswire Inc

Oct 19, 2020

08:00AM EDT STRATA Skin Sciences Announces: Expanding Medical Coverage for GlobeNewswire Inc

Oct 1, 2020

05:01PM EDT 4 Sectors Moving Up In Thursday's After-Market Session Benzinga

Sep 14, 2020

08:03AM EDT STRATA Skin Sciences Announces Recurring Revenue Direct Distribution Contract With JMEC Co., Ltd. In Japan Benzinga

08:00AM EDT STRATA Skin Sciences Announces New Recurring Revenue Direct GlobeNewswire Inc

Sep 8, 2020

08:00AM EDT STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (STRATA), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced Dr. Dolev Rafaeli, Chief Executive Officer will present at the following investor conferences: GlobeNewswire Inc

Aug 11, 2020

08:07AM EDT Recap: Strata Skin Sciences Q2 Earnings Benzinga

08:06AM EDT Strata Skin Sciences Q2 EPS $(0.05) Misses $(0.03) Estimate, Sales $4.03M Miss $5.13M Estimate Benzinga

08:00AM EDT Recurring revenue for the second quarter of 2020 was $2.8 million, a 52.1% decrease over second quarter 2019Total gross margins in the second quarter of 2020 was 48.7%, a 14.9% decrease over second quarter 2019Global recurring revenue installed base totaled 806 systems at June 30, 2020Conference call and webcast, today at 8:30 am Eastern Time GlobeNewswire Inc

04:02AM EDT Earnings Scheduled For August 11, 2020 Benzinga

Aug 4, 2020

08:00AM EDT STRATA Skin Sciences to Host Second Quarter 2020 Financial Results GlobeNewswire Inc

Share